Rebate Reprieve For Generics And Biosimilars Added To Build Back Better Act

Generics Facing Shortages And Biosimilars Are Now Exempt From Rebate Scheme

Wooden letters on dark background
Select generics and biosimilars have been exempted from Build Back Better's rebate scheme • Source: Alamy

More from Policy & Regulation

More from Generics Bulletin